Pliant Therapeutics Inc (PLRX)

Healthcare Pharmaceuticals & Medical Research Pharmaceuticals

Track

Stock chart

Ticker: PLRX Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-01-22	2025-01-22	PS Planned sale	Ouimette Mike General Counsel & Corp. Sec'y Officer	10,230 -12.7% 10.99 USD 112,462	10,230 -12.7%	10.99	USD 112,462
2025-01-22	2025-01-17	PS Planned sale	Hull Hans Chief Business Officer Officer	15,936 -7.0% 11.20 USD 178,501	15,936 -7.0%	11.20	USD 178,501
2025-01-22	2025-01-17	PS Planned sale	Coulie Bernard President and CEO Executive Director	52,419 -10.9% 11.20 USD 587,150	52,419 -10.9%	11.20	USD 587,150
2025-01-22	2025-01-17	PS Planned sale	Cummings Keith Lamont Chief Financial Officer Officer	20,148 -7.1% 11.20 USD 225,680	20,148 -7.1%	11.20	USD 225,680
2025-01-22	2025-01-17	PS Planned sale	Lefebvre Eric Chief Medical Officer Officer	18,478 -8.7% 11.20 USD 206,974	18,478 -8.7%	11.20	USD 206,974
2025-01-22	2025-01-17	PS Planned sale	Ouimette Mike General Counsel & Corp. Sec'y Officer	13,270 -14.1% 11.20 USD 148,639	13,270 -14.1%	11.20	USD 148,639
2025-01-22	2025-01-17	PS Planned sale	Cheung Lily Chief Human Resource Officer Officer	3,740 -13.2% 11.20 USD 41,892	3,740 -13.2%	11.20	USD 41,892
2024-07-12	2024-07-10	PS Planned sale	Ouimette Mike General Counsel & Corp. Sec'y Officer	7,656 -7.5% 11.56 USD 88,503	7,656 -7.5%	11.56	USD 88,503
2024-07-12	2024-07-10	PS Planned sale	Hull Hans Chief Business Officer Officer	9,900 -4.2% 11.56 USD 114,444	9,900 -4.2%	11.56	USD 114,444
2024-07-12	2024-07-10	PS Planned sale	Cummings Keith Lamont Chief Financial Officer Officer	10,911 -3.7% 11.56 USD 126,131	10,911 -3.7%	11.56	USD 126,131
2024-07-12	2024-07-10	PS Planned sale	Coulie Bernard President and CEO Executive Director	38,710 -7.4% 11.56 USD 447,488	38,710 -7.4%	11.56	USD 447,488
2024-07-12	2024-07-10	PS Planned sale	Lefebvre Eric Chief Medical Officer Officer	12,319 -5.5% 11.56 USD 142,408	12,319 -5.5%	11.56	USD 142,408
2024-01-19	2024-01-17	PS Planned sale	Ouimette Mike General Counsel & Corp. Sec'y Officer	5,197 -8.6% 17.23 USD 89,544	5,197 -8.6%	17.23	USD 89,544
2024-01-19	2024-01-17	PS Planned sale	Hull Hans Chief Business Officer Officer	9,786 -5.0% 17.23 USD 168,613	9,786 -5.0%	17.23	USD 168,613
2024-01-19	2024-01-17	PS Planned sale	Lefebvre Eric Chief Medical Officer Officer	10,295 -6.2% 17.23 USD 177,383	10,295 -6.2%	17.23	USD 177,383
2024-01-19	2024-01-17	PS Planned sale	Cummings Keith Lamont Chief Financial Officer Officer	9,781 -4.8% 17.23 USD 168,527	9,781 -4.8%	17.23	USD 168,527
2024-01-19	2024-01-17	PS Planned sale	Coulie Bernard President and CEO Executive Director	25,721 -7.5% 17.23 USD 443,173	25,721 -7.5%	17.23	USD 443,173
2023-08-07	2023-08-04	PS Planned sale	Hull Hans Chief Business Officer Officer	20,050 -9.3% 20.01 USD 401,201	20,050 -9.3%	20.01	USD 401,201
2023-08-07	2023-08-03	PS Planned sale	Hull Hans Chief Business Officer Officer	13,069 -6.0% 20.00 USD 261,380	13,069 -6.0%	20.00	USD 261,380
2023-07-21	2023-07-20	PS Planned sale	Ouimette Mike General Counsel & Corp. Sec'y Officer	4,755 -7.3% 17.55 USD 83,450	4,755 -7.3%	17.55	USD 83,450
2023-07-19	2023-07-17	PS Planned sale	Ouimette Mike General Counsel & Corp. Sec'y Officer	12,778 -16.4% 18.01 USD 230,120	12,778 -16.4%	18.01	USD 230,120
2023-07-19	2023-07-17	PS Planned sale	Lefebvre Eric Chief Medical Officer Officer	22,321 -11.8% 18.01 USD 401,981	22,321 -11.8%	18.01	USD 401,981
2023-07-19	2023-07-17	PS Planned sale	Cummings Keith Lamont Chief Financial Officer Officer	19,771 -8.8% 18.01 USD 356,058	19,771 -8.8%	18.01	USD 356,058
2023-07-19	2023-07-17	PS Planned sale	Coulie Bernard President and CEO Executive Director	70,150 -17.0% 18.01 USD 1,263,338	70,150 -17.0%	18.01	USD 1,263,338
2023-07-19	2023-07-17	PS Planned sale	Hull Hans Chief Business Officer Officer	17,937 -7.6% 18.01 USD 323,029	17,937 -7.6%	18.01	USD 323,029
2023-04-03	2023-04-03	PS Planned sale	Ouimette Mike General Counsel & Corp. Sec'y Officer	200 -0.4% 27.46 USD 5,491	200 -0.4%	27.46	USD 5,491
2023-04-03	2023-04-03	PS Planned sale	Ouimette Mike General Counsel & Corp. Sec'y Officer	2,677 -5.0% 26.74 USD 71,575	2,677 -5.0%	26.74	USD 71,575
2023-04-03	2023-03-30	PS Planned sale	Cummings Keith Lamont Chief Financial Officer Officer	9,960 -6.3% 26.52 USD 264,148	9,960 -6.3%	26.52	USD 264,148
2023-04-03	2023-03-30	PS Planned sale	Lefebvre Eric Chief Medical Officer Officer	11,245 -7.2% 26.52 USD 298,228	11,245 -7.2%	26.52	USD 298,228
2023-04-03	2023-03-30	PS Planned sale	Hull Hans Chief Business Officer Officer	9,036 -4.3% 26.52 USD 239,643	9,036 -4.3%	26.52	USD 239,643
2023-04-03	2023-03-30	PS Planned sale	Ouimette Mike General Counsel & Corp. Sec'y Officer	4,874 -8.3% 26.52 USD 129,263	4,874 -8.3%	26.52	USD 129,263
2023-04-03	2023-03-30	PS Planned sale	Coulie Bernard President and CEO Executive Director	35,339 -11.4% 26.52 USD 937,222	35,339 -11.4%	26.52	USD 937,222
2023-02-06	2023-02-03	PS Planned sale	Coulie Bernard President and CEO Executive Director	5,262 -2.1% 34.08 USD 179,312	5,262 -2.1%	34.08	USD 179,312
2023-02-06	2023-02-03	PS Planned sale	Coulie Bernard President and CEO Executive Director	9,738 -3.8% 33.36 USD 324,888	9,738 -3.8%	33.36	USD 324,888
2023-02-06	2023-02-02	PS Planned sale	Coulie Bernard President and CEO Executive Director	1,605 -0.7% 34.96 USD 56,105	1,605 -0.7%	34.96	USD 56,105
2023-02-06	2023-02-02	PS Planned sale	Coulie Bernard President and CEO Executive Director	13,395 -5.3% 34.13 USD 457,124	13,395 -5.3%	34.13	USD 457,124
2023-02-01	2023-02-01	PS Planned sale	Coulie Bernard President and CEO Executive Director	105 -0.0% 35.55 USD 3,733	105 -0.0%	35.55	USD 3,733
2023-02-01	2023-02-01	PS Planned sale	Coulie Bernard President and CEO Executive Director	5,440 -2.2% 34.78 USD 189,192	5,440 -2.2%	34.78	USD 189,192
2023-02-01	2023-02-01	PS Planned sale	Coulie Bernard President and CEO Executive Director	9,455 -3.7% 34.15 USD 322,841	9,455 -3.7%	34.15	USD 322,841
2023-02-01	2023-01-31	PS Planned sale	Coulie Bernard President and CEO Executive Director	15,000 -5.9% 34.92 USD 523,755	15,000 -5.9%	34.92	USD 523,755
2023-02-01	2023-01-30	PS Planned sale	Coulie Bernard President and CEO Executive Director	3,605 -1.5% 34.66 USD 124,938	3,605 -1.5%	34.66	USD 124,938
2023-02-01	2023-01-30	PS Planned sale	Coulie Bernard President and CEO Executive Director	11,395 -4.5% 33.98 USD 387,177	11,395 -4.5%	33.98	USD 387,177
2023-01-27	2023-01-27	PS Planned sale	Coulie Bernard President and CEO Executive Director	221 -0.1% 36.64 USD 8,097	221 -0.1%	36.64	USD 8,097
2023-01-27	2023-01-27	PS Planned sale	Coulie Bernard President and CEO Executive Director	9,779 -2.3% 35.09 USD 343,158	9,779 -2.3%	35.09	USD 343,158
2023-01-27	2023-01-27	PS Planned sale	Coulie Bernard President and CEO Executive Director	6,302 -2.6% 36.06 USD 227,243	6,302 -2.6%	36.06	USD 227,243
2023-01-27	2023-01-27	PS Planned sale	Coulie Bernard President and CEO Executive Director	8,698 -3.4% 35.42 USD 308,046	8,698 -3.4%	35.42	USD 308,046
2023-01-27	2023-01-26	PS Planned sale	Coulie Bernard President and CEO Executive Director	15,000 -3.5% 35.10 USD 526,425	15,000 -3.5%	35.10	USD 526,425
2023-01-27	2023-01-26	PS Planned sale	Coulie Bernard President and CEO Executive Director	15,000 -5.9% 35.29 USD 529,367	15,000 -5.9%	35.29	USD 529,367
2023-01-25	2023-01-25	PS Planned sale	Coulie Bernard President and CEO Executive Director	1,696 -1.8% 33.29 USD 56,459	1,696 -1.8%	33.29	USD 56,459
2023-01-25	2023-01-25	PS Planned sale	Coulie Bernard President and CEO Executive Director	13,304 -12.2% 32.40 USD 431,058	13,304 -12.2%	32.40	USD 431,058
2023-01-25	2023-01-24	PS Planned sale	Coulie Bernard President and CEO Executive Director	15,000 -13.8% 30.89 USD 463,389	15,000 -13.8%	30.89	USD 463,389
2023-01-25	2023-01-23	PS Planned sale	Cummings Keith Lamont Chief Financial Officer Officer	30,000 -26.2% 35.00 USD 1,050,000	30,000 -26.2%	35.00	USD 1,050,000
2023-01-25	2023-01-23	PS Planned sale	Coulie Bernard President and CEO Executive Director	15,000 -3.3% 35.00 USD 525,000	15,000 -3.3%	35.00	USD 525,000
2023-01-25	2023-01-23	PS Planned sale	Coulie Bernard President and CEO Executive Director	4,850 -4.9% 34.93 USD 169,405	4,850 -4.9%	34.93	USD 169,405
2023-01-25	2023-01-23	PS Planned sale	Coulie Bernard President and CEO Executive Director	10,150 -9.3% 33.71 USD 342,163	10,150 -9.3%	33.71	USD 342,163
2023-01-25	2023-01-23	PS Planned sale	Ouimette Mike General Counsel & Corp. Sec'y Officer	20,000 -77.1% 34.19 USD 683,878	20,000 -77.1%	34.19	USD 683,878
2023-01-25	2023-01-23	PS Planned sale	Lefebvre Eric Chief Medical Officer Officer	67,500 -46.7% 34.48 USD 2,327,630	67,500 -46.7%	34.48	USD 2,327,630
2023-01-09	2023-01-09	PS Planned sale	Coulie Bernard President and CEO Executive Director	5,000 -5.1% 19.17 USD 95,829	5,000 -5.1%	19.17	USD 95,829
2023-01-09	2023-01-06	PS Planned sale	Coulie Bernard President and CEO Executive Director	15,000 -13.8% 19.04 USD 285,584	15,000 -13.8%	19.04	USD 285,584
2023-01-05	2023-01-04	PS Planned sale	Coulie Bernard President and CEO Executive Director	15,000 -13.8% 19.06 USD 285,941	15,000 -13.8%	19.06	USD 285,941
2023-01-05	2023-01-03	PS Planned sale	Coulie Bernard President and CEO Executive Director	15,000 -13.8% 19.33 USD 289,952	15,000 -13.8%	19.33	USD 289,952
2022-12-23	2022-12-22	PS Planned sale	Ouimette Mike General Counsel & Corp. Sec'y Officer	2,928 -33.0% 19.38 USD 56,731	2,928 -33.0%	19.38	USD 56,731
2022-12-21	2022-12-20	S Sale	Coulie Bernard President and CEO Executive Director	34,212 -26.7% 19.10 USD 653,531	34,212 -26.7%	19.10	USD 653,531
2022-12-21	2022-12-20	S Sale	Hull Hans Chief Business Officer Officer	8,748 -6.0% 19.10 USD 167,108	8,748 -6.0%	19.10	USD 167,108
2022-12-21	2022-12-20	S Sale	Ouimette Mike General Counsel & Corp. Sec'y Officer	4,719 -34.7% 19.10 USD 90,144	4,719 -34.7%	19.10	USD 90,144
2022-12-21	2022-12-20	S Sale	Lefebvre Eric Chief Medical Officer Officer	10,887 -7.0% 19.10 USD 207,968	10,887 -7.0%	19.10	USD 207,968
2022-12-21	2022-12-20	S Sale	Cummings Keith Lamont Chief Financial Officer Officer	9,643 -10.7% 19.10 USD 184,204	9,643 -10.7%	19.10	USD 184,204
2022-10-27	2022-10-25	PS Planned sale	Lefebvre Eric Chief Medical Officer Officer	5,000 -3.6% 25.05 USD 125,241	5,000 -3.6%	25.05	USD 125,241
2022-09-14	2022-09-12	PS Planned sale	Coulie Bernard President and CEO Executive Director	12,502 -17.4% 22.54 USD 281,851	12,502 -17.4%	22.54	USD 281,851
2022-07-13	2022-07-12	PS Planned sale	Coulie Bernard President and CEO Executive Director	12,498 -17.4% 22.50 USD 281,205	12,498 -17.4%	22.50	USD 281,205
2022-07-13	2022-07-11	PS Planned sale	Coulie Bernard President and CEO Executive Director	15,000 -20.2% 22.50 USD 337,500	15,000 -20.2%	22.50	USD 337,500
2022-07-13	2022-07-11	PS Planned sale	Lefebvre Eric Chief Medical Officer Officer	3,000 -2.1% 20.00 USD 60,000	3,000 -2.1%	20.00	USD 60,000
2021-06-22	2021-06-18	PS Planned sale	Lefebvre Eric Chief Medical Officer Officer	22 -0.0% 30.23 USD 665	22 -0.0%	30.23	USD 665
2021-06-22	2021-06-18	PS Planned sale	Lefebvre Eric Chief Medical Officer Officer	3,728 -2.6% 29.43 USD 109,718	3,728 -2.6%	29.43	USD 109,718
2021-06-22	2021-06-18	PS Planned sale	Lefebvre Eric Chief Medical Officer Officer	8,750 -5.8% 28.62 USD 250,438	8,750 -5.8%	28.62	USD 250,438

Pliant Therapeutics Inc (PLRX)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by